CNPR Drug Development Process 2

Question 1

Which regulatory submission allows a pharmaceutical company to begin human clinical trials in the US?

Accepted Answer

Investigational New Drug (IND) Application

Answer

An IND application must be filed with the FDA and allowed to proceed before any human clinical testing can begin.

Question 2

What is the primary purpose of a Phase II clinical trial?

Accepted Answer

To assess efficacy and further evaluate safety in a larger patient population

Answer

Phase II trials enroll patients with the target disease to gather preliminary efficacy data and continue safety evaluation.

Question 3

The Hatch-Waxman Act (1984) was primarily designed to:

Accepted Answer

Facilitate generic drug entry by clarifying patent and data exclusivity rules

Answer

Hatch-Waxman created the ANDA pathway and patent challenge mechanisms that allow generic drugs to reach market more quickly after brand exclusivity expires.

Question 4

In drug development, 'ADME' refers to which four pharmacokinetic processes?

Accepted Answer

Absorption, Distribution, Metabolism, Excretion

Answer

ADME describes how a drug is absorbed into the body, distributed to tissues, metabolized (chemically transformed), and excreted.

Question 5

Which FDA designation is granted to drugs targeting serious conditions where the drug demonstrates substantial improvement over available therapies?

Accepted Answer

Breakthrough Therapy Designation

Answer

Breakthrough Therapy Designation provides intensive FDA guidance and may expedite development for drugs showing early clinical evidence of substantial improvement.

(CNPR) Certified National Pharmaceutical Representative Practice Test

(CNPR) Certified National Pharmaceutical Representative Practice Test

CNPR Drug Development Process 2